Jump to content

Genedata Selector: Next Generation Sequencing Based Biosafety Assessment of Biologics in a Validated Environment

PDA Virus Conference 2024, Amsterdam, The Netherlands
June 14, 2024

Biopharmaceutical companies use Good Manufacturing Practice (GMP) guidelines to guarantee the safety of their biotherapeutic products. As a replacement for traditional assays, Next-Generation Sequencing (NGS) technology is becoming more prevalent in GMP settings. NGS plays a crucial role in preventing and identifying biological contamination throughout the manufacturing process, thereby ensuring product efficacy. Moreover, the ICHQ5A (R2) guideline advocates for the use of NGS as a substitute for animal testing. The Genedata Selector® software streamlines the analysis of NGS-based data workflows, creating a single source of truth across various NGS instruments and assays. This software is equipped with functionalities required by GMP, and Genedata provides validation support services for CSV projects.


Request Resource

By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Genedata privacy policy